PhRMA Perspectives on Drug Substance Regulatory Filing Issues

February 2, 2003

Michael Mitchell is vice-president of chemical development at Schering-Plough Research Institute.

Pharmaceutical Technology, Pharmaceutical Technology-02-02-2003, Volume 27, Issue 2

The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.